Key result
Unvaccinated symptomatic COVID-19 is linked to ~19% higher myocardial extracellular volume versus vaccinated patients.
Why the study?
Changes in myocardial extracellular volume and fibrosis volume are early prognostic markers, but their status after SARS-CoV-2 infection according to COVID-19 vaccination status required assessment.
Does full COVID-19 vaccination prior to symptomatic SARS-CoV-2 infection prevent increases in myocardial extracellular volume and fibrosis volume compared to unvaccinated patients?
Cross-Sectional (n=97)
No
Does full COVID-19 vaccination prior to symptomatic SARS-CoV-2 infection prevent increases in myocardial extracellular volume and fibrosis volume compared to unvaccinated patients?
Full vaccination against COVID-19 prior to SARS-CoV-2 infection is associated with significantly lower myocardial extracellular volume and fibrosis volume on CMR compared to unvaccinated patients, suggesting a protective effect against virus-mediated diffuse myocardial structural changes.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for vaccination mitigating post-infection myocardial fibrosis; randomized trials needed before clinical consideration.
Cardiac magnetic resonance (CMR) enables the assessment of tissue characteristics of the myocardium. Changes in the extracellular volume (ECV) and fibrosis volume (FV) of the myocardium are sensitive and early pathogenetic markers and have prognostic significance. The aim of the study was to assess ECV and FV of left ventricular myocardium in T1 mapping sequence in patients with a history of SARS-CoV-2 infection, considering vaccination status against COVID-19. The study group consisted of 97 patients (52.54 ± 8.31 years, 53% women and 47% men). The participants were divided into three subgroups: A) patients with a history of symptomatic SARS-CoV-2 infection, unvaccinated against COVID-19 (n = 39), B) patients with a history of symptomatic SARS-CoV-2 infection, with a full vaccination schedule against COVID-19 (n = 22), and C) persons without a history of SARS-CoV-2 infection constituting the control subgroup (C, n = 36). All patients underwent 1.5 T cardiac magnetic resonance. In subgroup A compared to subgroups B and C, both the ECV whole myocardium and ECV segments 2, 5-6, 8, and 10-11 were statistically significantly higher. In addition, the ECV segment 16 was statistically significantly higher in subgroup A than in subgroup C. Also, the FV whole myocardium was statistically significantly higher in subgroup A in comparison to subgroups B and C. There were no significant differences in ECV and FV between subgroups B and C. In summary, unvaccinated against COVID-19 patients with a history of symptomatic SARS-CoV-2 infection have higher myocardial ECV and FV values in the T1 mapping sequence, compared to those without COVID-19 and those suffering from COVID-19, previously vaccinated with the full vaccination schedule.
No takes yet. Share an insight, caveat, or question.
Gać et al. (2024) conducted a cross-sectional in History of symptomatic SARS-CoV-2 infection (n=97). Symptomatic SARS-CoV-2 infection without prior COVID-19 vaccination vs. Symptomatic SARS-CoV-2 infection with full prior COVID-19 vaccination, and no history of SARS-CoV-2 infection was evaluated on Extracellular volume (ECV) of the whole myocardium (p=0.003). Unvaccinated patients with a history of symptomatic SARS-CoV-2 infection had higher myocardial extracellular volume and fibrosis volume compared to fully vaccinated patients with prior infection.
Synapse has enriched 10 related papers. Consider them for comparative context: